Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with…
152 million babies born preterm in the last decade
152 million babies born preterm in the last decade An estimated 13.4 million babies were born pre-term in 2020, with nearly 1 million dying from preterm complications, according to a…
Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic
Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic The WHO Director-General has the pleasure of transmitting the Report of the fifteenth meeting of…
UAE and WHO deliver air lift of critical medical supplies to Sudan
UAE and WHO deliver air lift of critical medical supplies to Sudan The United Arab Emirates (UAE) and the World Health Organization have delivered 30 tons of urgent medical supplies…
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD) Ultomiris (ravulizumab) has been approved in the European Union (EU) as the first and only long-acting C5 complement…
Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to…
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas The approval by the National Medical Products Administration (NMPA) in China was based on positive results…
Syneos Health Appoints Michael Bonello as Chief Financial Officer
Syneos Health Appoints Michael Bonello as Chief Financial Officer Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael Bonello as Chief Financial Officer, effective…
Boehringer Ingelheim and German Chancellor Olaf Scholz lay the foundation stone for the 285 million EUR innovation center
Boehringer Ingelheim and German Chancellor Olaf Scholz lay the foundation stone for 285 million EUR innovation center Boehringer Ingelheim breaks ground to build a new Chemical Innovation Plant at its…
New survey results show health systems starting to recover from pandemic
New survey results show health systems starting to recover from pandemic After three years of the COVID-19 pandemic, health systems in countries have started showing the first major signs of…
African Parliamentarians rally to boost life-saving laws, regulations on road safety
African Parliamentarians rally to boost life-saving laws, regulations on road safety Parliamentarians, policy-makers and experts from 10 African countries met today to strengthen laws and actions to curb the scourge…
Up to 73% of Atopic Dermatitis Patients Taking Lilly’s Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis
Up to 73% of Atopic Dermatitis Patients Taking Lilly’s Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis New secondary analysis from Eli Lilly and Company’s (NYSE: LLY)…